Rx/Reimbursement Adult Incontinence in the US
Rising consumer awareness around incontinence and proper condition management, partnerships with direct-to-consumer platforms and the expanding 65+ year-old population in the US all contributed to healthy value and volume growth in the Rx/reimbursement adult incontinence market in 2023.
Euromonitor International's Rx/Reimbursement adult incontinence in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2028 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Rx/Reimbursement Adult Incontinence in the US
- Euromonitor International
- February 2024
- List Of Contents And Tables
- RX/REIMBURSEMENT ADULT INCONTINENCE IN THE US
- KEY DATA FINDINGS
- 2023 DEVELOPMENTS
- Rx/reimbursement continues to see steady growth, even amid the cessation of COVID-19 emergency relief funding
- Funding constraints limit product options
- Florida lawsuit settlements prompt expanded coverage of incontinence products
- PROSPECTS AND OPPORTUNITIES
- Future policy will be a key driver of the category’s long-term performance
- Brands and direct-to-consumer retailers’ education and alliances are essential for the reimbursement consumer
- CATEGORY DATA
- Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2018-2023
- Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2018-2023
- Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2023-2028
- Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2023-2028
- TISSUE AND HYGIENE IN THE US
- EXECUTIVE SUMMARY
- Tissue and hygiene in 2023: The big picture
- 2023 key trends
- Competitive landscape
- Retailing developments
- What next for tissue and hygiene?
- MARKET INDICATORS
- Table 5 Birth Rates 2018-2023
- Table 6 Infant Population 2018-2023
- Table 7 Female Population by Age 2018-2023
- Table 8 Total Population by Age 2018-2023
- Table 9 Households 2018-2023
- Table 10 Forecast Infant Population 2023-2028
- Table 11 Forecast Female Population by Age 2023-2028
- Table 12 Forecast Total Population by Age 2023-2028
- Table 13 Forecast Households 2023-2028
- MARKET DATA
- Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2018-2023
- Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2018-2023
- Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2019-2023
- Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2020-2023
- Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2018-2023
- Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2018-2023
- Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2023
- Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2023-2028
- Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2023-2028
- DISCLAIMER
- SOURCES
- Summary 1 Research Sources
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook